Physician profile
Amarjit Singh
NPI 1982890539
$491.37
in general payments reported to CMS, 2019-2025
9 companies · $67.17 in 2025
The $67.17 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $208 · 2021: $85.00 · 2023: $88.48 · 2024: $42.77 · 2025: $67.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $156 · Education: $42.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $155.92 |
| Education | $42.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $144.27 | 2019-2023 | Puraply |
| Smith+Nephew, INC. | $133.10 | 2019 | |
| Mannkind Corporation | $67.17 | 2025 | |
| Grifols USA, LLC | $45.39 | 2023-2024 | Prolastin-C Liquid |
| Novo Nordisk INC | $29.58 | 2019 | |
| Electromed, INC. | $22.85 | 2024 | Smartvest |
| Ultragenyx Pharmaceutical INC. | $20.29 | 2021 | |
| Hologic Sales and Service, LLC | $14.49 | 2023 | Myosure Tissue Removal Device |
| Tactile Systems Technology INC | $14.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amarjit Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.